Do different classes of antihypertensive drugs affect outcomes in patients with COVID-19 and hypertension?
This review discusses the effects of various antihypertensive drug classes on patients with concurrent COVID-19 and hypertension.
Hypertension is a major risk factor for cardiovascular disease. Previous studies showed that patients with hypertension are at an increased risk of developing severe COVID-19 infection. Therefore, proper blood pressure control in hypertensive patients with COVID-19 is of great importance. In this review, we discussed the effects of different classes of antihypertensive drugs on patients with hypertension and COVID-19.
Nozari et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: